Equus asinus breed Dezhou chromosome 18, ASM1607732v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
Donkey genomes provide new insights into domestication and selection for coat color
REFSEQ INFORMATION: The reference sequence is identical to\nCM027707.2.\nAssembly name: ASM1607732v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Dairy Cattle Research Center,\nShandong Academy of Agricultural Sciences on 2021/10/14. The\noriginal whole-genome shotgun project has the accession\nJADWZW000000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Dairy Cattle Research Center, Shandong\n Academy of Agricultural Sciences\nAssembly Method :: SOAPdenovo v. 2.04.4; DBG2OLC v. 1;\n 3D-DNA v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 211.0x\nSequencing Technology :: Illumina HiSeq; PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Equus asinus Annotation Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 9-like isoform X1
disintegrin and metalloproteinase domain-containing protein 9-like isoform X2
disintegrin and metalloproteinase domain-containing protein 2, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 2, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 2, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 2, transcript variant X6
disintegrin and metalloproteinase domain-containing protein 2, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 2, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 2 isoform X1
disintegrin and metalloproteinase domain-containing protein 2 isoform X4
disintegrin and metalloproteinase domain-containing protein 2 isoform X2
disintegrin and metalloproteinase domain-containing protein 2 isoform X3
disintegrin and metalloproteinase domain-containing protein 18-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 18-like, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 18-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 18-like, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 18-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 18-like isoform X2
disintegrin and metalloproteinase domain-containing protein 18-like isoform X3
disintegrin and metalloproteinase domain-containing protein 18-like isoform X1
disintegrin and metalloproteinase domain-containing protein 18-like isoform X4
disintegrin and metalloproteinase domain-containing protein 18-like isoform X5
uncharacterized LOC123278238, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123278238, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 5-like isoform X2
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 5-like isoform X1
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 32-like isoform X5
disintegrin and metalloproteinase domain-containing protein 32-like isoform X3
disintegrin and metalloproteinase domain-containing protein 32-like isoform X4
disintegrin and metalloproteinase domain-containing protein 32-like isoform X2
disintegrin and metalloproteinase domain-containing protein 32-like isoform X1
disintegrin and metalloproteinase domain-containing protein 32-like isoform X6
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X9
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X8
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X7
disintegrin and metalloproteinase domain-containing protein 32-like isoform X9
disintegrin and metalloproteinase domain-containing protein 32-like isoform X8
disintegrin and metalloproteinase domain-containing protein 32-like isoform X7
uncharacterized LOC106824217, transcript variant X1
uncharacterized LOC106824217, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X6
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X7
disintegrin and metalloproteinase domain-containing protein 5-like isoform X6
putative disintegrin and metalloproteinase domain-containing protein 5 isoform X3
putative disintegrin and metalloproteinase domain-containing protein 5 isoform X1
disintegrin and metalloproteinase domain-containing protein 5-like isoform X5
disintegrin and metalloproteinase domain-containing protein 5-like isoform X7
disintegrin and metalloproteinase domain-containing protein 5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
putative disintegrin and metalloproteinase domain-containing protein 5 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 47% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metallopeptidase domain 3
uncharacterized LOC123278288, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X11
uncharacterized LOC123278288, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC123278288, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
indoleamine 2,3-dioxygenase 1, transcript variant X2
indoleamine 2,3-dioxygenase 1, transcript variant X1
indoleamine 2,3-dioxygenase 1, transcript variant X3
indoleamine 2,3-dioxygenase 1, transcript variant X4
indoleamine 2,3-dioxygenase 2, transcript variant X1
indoleamine 2,3-dioxygenase 2 isoform X1
indoleamine 2,3-dioxygenase 2, transcript variant X2
indoleamine 2,3-dioxygenase 2 isoform X2
transcriptional and immune response regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcriptional and immune response regulator
zinc finger matrin-type 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger matrin-type 4, transcript variant X3
zinc finger matrin-type 4, transcript variant X2
zinc finger matrin-type protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
zinc finger matrin-type 4, transcript variant X1
zinc finger matrin-type 4, transcript variant X5
zinc finger matrin-type protein 4 isoform X1
zinc finger matrin-type protein 4 isoform X3
GINS complex subunit 4, transcript variant X2
GINS complex subunit 4, transcript variant X1
DNA replication complex GINS protein SLD5 isoform X1
DNA replication complex GINS protein SLD5 isoform X2
uncharacterized LOC123278388, transcript variant X2
uncharacterized LOC123278388, transcript variant X1
glycerol-3-phosphate acyltransferase 4, transcript variant X4
glycerol-3-phosphate acyltransferase 4, transcript variant X1
glycerol-3-phosphate acyltransferase 4, transcript variant X2
glycerol-3-phosphate acyltransferase 4, transcript variant X3
glycerol-3-phosphate acyltransferase 4 isoform X1
glycerol-3-phosphate acyltransferase 4 isoform X2
glycerol-3-phosphate acyltransferase 4, transcript variant X5
glycerol-3-phosphate acyltransferase 4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histone acetyltransferase KAT6A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
adaptor related protein complex 3 subunit mu 2, transcript variant X2
adaptor related protein complex 3 subunit mu 2, transcript variant X1
adaptor related protein complex 3 subunit mu 2, transcript variant X3
adaptor related protein complex 3 subunit mu 2, transcript variant X5
adaptor related protein complex 3 subunit mu 2, transcript variant X4
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X4
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X3
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X3
dickkopf WNT signaling pathway inhibitor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage dependent anion channel 3, transcript variant X1
voltage dependent anion channel 3, transcript variant X2
voltage-dependent anion-selective channel protein 3 isoform X1
voltage-dependent anion-selective channel protein 3 isoform X2
solute carrier family 20 member 2, transcript variant X9
solute carrier family 20 member 2, transcript variant X3
solute carrier family 20 member 2, transcript variant X7
solute carrier family 20 member 2, transcript variant X5
solute carrier family 20 member 2, transcript variant X2
solute carrier family 20 member 2, transcript variant X8
solute carrier family 20 member 2, transcript variant X4
solute carrier family 20 member 2, transcript variant X1
solute carrier family 20 member 2, transcript variant X6
solute carrier family 20 member 2, transcript variant X10
solute carrier family 20 member 2, transcript variant X11
sodium-dependent phosphate transporter 2 isoform X1
sodium-dependent phosphate transporter 2 isoform X2
small integral membrane protein 19, transcript variant X1
small integral membrane protein 19, transcript variant X4
small integral membrane protein 19, transcript variant X7
small integral membrane protein 19, transcript variant X3
small integral membrane protein 19, transcript variant X6
small integral membrane protein 19, transcript variant X5
small integral membrane protein 19, transcript variant X2
cholinergic receptor nicotinic beta 3 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cholinergic receptor nicotinic beta 3 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cholinergic receptor nicotinic beta 3 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-3
cholinergic receptor nicotinic alpha 6 subunit
neuronal acetylcholine receptor subunit alpha-6
ring finger protein 170, transcript variant X6
ring finger protein 170, transcript variant X4
ring finger protein 170, transcript variant X2
ring finger protein 170, transcript variant X1
ring finger protein 170, transcript variant X3
ring finger protein 170, transcript variant X5
E3 ubiquitin-protein ligase RNF170 isoform X2
E3 ubiquitin-protein ligase RNF170 isoform X1
E3 ubiquitin-protein ligase RNF170 isoform X3
hook microtubule tethering protein 3, transcript variant X1
hook microtubule tethering protein 3, transcript variant X2
hook microtubule tethering protein 3, transcript variant X3
hook microtubule tethering protein 3, transcript variant X4
hook microtubule tethering protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
protein O-mannose kinase, transcript variant X2
protein O-mannose kinase, transcript variant X1
protein O-mannose kinase, transcript variant X4
protein O-mannose kinase, transcript variant X7
protein O-mannose kinase, transcript variant X5
protein O-mannose kinase, transcript variant X6
protein O-mannose kinase, transcript variant X3
heparan-alpha-glucosaminide N-acetyltransferase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: heparan-alpha-glucosaminide N-acetyltransferase
integrator complex subunit 10, transcript variant X1
integrator complex subunit 10, transcript variant X2
integrator complex subunit 10, transcript variant X4
integrator complex subunit 10 isoform X2
integrator complex subunit 10 isoform X1
integrator complex subunit 10 isoform X4
integrator complex subunit 10, transcript variant X3
integrator complex subunit 10 isoform X3
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X1
uncharacterized LOC123278377, transcript variant X2
uncharacterized LOC123278377, transcript variant X3
uncharacterized LOC123278377, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123278377, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X6
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X5
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X3
SH2 domain containing 4A, transcript variant X2
SH2 domain containing 4A, transcript variant X4
SH2 domain containing 4A, transcript variant X3
SH2 domain containing 4A, transcript variant X1
SH2 domain-containing protein 4A isoform X4
SH2 domain-containing protein 4A isoform X2
SH2 domain-containing protein 4A isoform X3
SH2 domain-containing protein 4A isoform X1
pleckstrin and Sec7 domain containing 3, transcript variant X1
pleckstrin and Sec7 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
PH and SEC7 domain-containing protein 3 isoform X1
PH and SEC7 domain-containing protein 3 isoform X2
pleckstrin and Sec7 domain containing 3, transcript variant X3
PH and SEC7 domain-containing protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
arylamine N-acetyltransferase 1, transcript variant X4
arylamine N-acetyltransferase 1, transcript variant X3
arylamine N-acetyltransferase 1, transcript variant X2
arylamine N-acetyltransferase 1, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: aryl hydrocarbon receptor-like
uncharacterized LOC123278274, transcript variant X1
uncharacterized LOC123278274, transcript variant X3
uncharacterized LOC123278274, transcript variant X2
protein arginine methyltransferase 2, transcript variant X5
protein arginine methyltransferase 2, transcript variant X10
protein arginine methyltransferase 2, transcript variant X4
protein arginine methyltransferase 2, transcript variant X7
protein arginine methyltransferase 2, transcript variant X1
protein arginine methyltransferase 2, transcript variant X8
protein arginine methyltransferase 2, transcript variant X3
protein arginine methyltransferase 2, transcript variant X9
protein arginine methyltransferase 2, transcript variant X2
protein arginine methyltransferase 2, transcript variant X6
protein arginine methyltransferase 2, transcript variant X11
protein arginine N-methyltransferase 2 isoform X2
protein arginine N-methyltransferase 2 isoform X1
protein arginine methyltransferase 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
protein arginine N-methyltransferase 2 isoform X3
disco interacting protein 2 homolog A, transcript variant X4
disco interacting protein 2 homolog A, transcript variant X5
disco interacting protein 2 homolog A, transcript variant X2
disco interacting protein 2 homolog A, transcript variant X3
disco interacting protein 2 homolog A, transcript variant X1
disco interacting protein 2 homolog A, transcript variant X7
disco interacting protein 2 homolog A, transcript variant X8
disco interacting protein 2 homolog A, transcript variant X6
disco-interacting protein 2 homolog A isoform X4
disco-interacting protein 2 homolog A isoform X5
disco-interacting protein 2 homolog A isoform X2
disco-interacting protein 2 homolog A isoform X3
disco-interacting protein 2 homolog A isoform X1
disco-interacting protein 2 homolog A isoform X6
disco interacting protein 2 homolog A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
disco-interacting protein 2 homolog A isoform X7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein C21orf58 homolog
ybeY metalloendoribonuclease, transcript variant X1
ybeY metalloendoribonuclease, transcript variant X4
ybeY metalloendoribonuclease, transcript variant X3
ybeY metalloendoribonuclease, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
minichromosome maintenance complex component 3 associated protein, transcript variant X2
minichromosome maintenance complex component 3 associated protein, transcript variant X1
minichromosome maintenance complex component 3 associated protein, transcript variant X3
germinal-center associated nuclear protein isoform X1
germinal-center associated nuclear protein isoform X3
germinal-center associated nuclear protein isoform X2
lanosterol synthase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
lanosterol synthase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
lanosterol synthase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
lanosterol synthase, transcript variant X1
lanosterol synthase, transcript variant X2
lanosterol synthase, transcript variant X6
spermatogenesis and centriole associated 1 like
formimidoyltransferase cyclodeaminase, transcript variant X1
formimidoyltransferase cyclodeaminase, transcript variant X2
formimidoyltransferase cyclodeaminase, transcript variant X3
formimidoyltransferase cyclodeaminase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
formimidoyltransferase-cyclodeaminase isoform X1
formimidoyltransferase-cyclodeaminase isoform X2
formimidoyltransferase-cyclodeaminase isoform X3
formimidoyltransferase-cyclodeaminase isoform X4
uncharacterized LOC123278300, transcript variant X2
uncharacterized LOC123278300, transcript variant X3
uncharacterized LOC123278300, transcript variant X1
uncharacterized LOC123278301, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123278301, transcript variant X1
uncharacterized LOC123278301, transcript variant X2
uncharacterized LOC123278301, transcript variant X4
poly(rC) binding protein 3, transcript variant X5
poly(rC) binding protein 3, transcript variant X3
poly(rC) binding protein 3, transcript variant X4
poly(rC) binding protein 3, transcript variant X10
poly(rC) binding protein 3, transcript variant X7
poly(rC) binding protein 3, transcript variant X6
poly(rC) binding protein 3, transcript variant X2
poly(rC) binding protein 3, transcript variant X1
poly(rC) binding protein 3, transcript variant X14
poly(rC) binding protein 3, transcript variant X9
poly(rC) binding protein 3, transcript variant X13
poly(rC) binding protein 3, transcript variant X8
poly(rC) binding protein 3, transcript variant X11
poly(rC) binding protein 3, transcript variant X12
poly(rC) binding protein 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 19 member 1, transcript variant X1
solute carrier family 19 member 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-1(XVIII) chain
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein O-fucosyltransferase 2, transcript variant X1
protein O-fucosyltransferase 2, transcript variant X3
protein O-fucosyltransferase 2, transcript variant X2
protein O-fucosyltransferase 2, transcript variant X4
protein O-fucosyltransferase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
protein O-fucosyltransferase 2, transcript variant X5
GDP-fucose protein O-fucosyltransferase 2 isoform X1
GDP-fucose protein O-fucosyltransferase 2 isoform X3
GDP-fucose protein O-fucosyltransferase 2 isoform X2
GDP-fucose protein O-fucosyltransferase 2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
adenosine deaminase RNA specific B1, transcript variant X1
adenosine deaminase RNA specific B1, transcript variant X2
adenosine deaminase RNA specific B1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
double-stranded RNA-specific editase 1 isoform X1
double-stranded RNA-specific editase 1 isoform X2
leucine-rich repeat extensin-like protein 5
uncharacterized LOC123278333, transcript variant X1
uncharacterized LOC123278333, transcript variant X2
SLX9 ribosome biogenesis factor, transcript variant X1
SLX9 ribosome biogenesis factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
integrin beta-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
integrin beta-2-like, transcript variant X4
integrin beta-2-like, transcript variant X1
integrin beta-2-like, transcript variant X3
integrin beta-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: integrin beta-2-like
pituitary tumor-transforming gene 1 protein-interacting protein
ubiquitin conjugating enzyme E2 G2, transcript variant X1
ubiquitin conjugating enzyme E2 G2, transcript variant X2
ubiquitin-conjugating enzyme E2 G2 isoform X1
ubiquitin-conjugating enzyme E2 G2 isoform X2
uncharacterized LOC123278366, transcript variant X1
uncharacterized LOC123278366, transcript variant X2
thrombospondin type laminin G domain and EAR repeats, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
thrombospondin type laminin G domain and EAR repeats, transcript variant X2
thrombospondin-type laminin G domain and EAR repeat-containing protein isoform X1
thrombospondin-type laminin G domain and EAR repeat-containing protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: keratin-associated protein 10-4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
LOW QUALITY PROTEIN: keratin-associated protein 10-1-like
leucine-rich repeat-containing protein 3
transient receptor potential cation channel subfamily M member 2, transcript variant X8
transient receptor potential cation channel subfamily M member 2, transcript variant X5
transient receptor potential cation channel subfamily M member 2, transcript variant X7
transient receptor potential cation channel subfamily M member 2, transcript variant X4
transient receptor potential cation channel subfamily M member 2, transcript variant X3
transient receptor potential cation channel subfamily M member 2, transcript variant X9
transient receptor potential cation channel subfamily M member 2, transcript variant X1
transient receptor potential cation channel subfamily M member 2, transcript variant X2
transient receptor potential cation channel subfamily M member 2, transcript variant X13
transient receptor potential cation channel subfamily M member 2, transcript variant X6
transient receptor potential cation channel subfamily M member 2, transcript variant X10
transient receptor potential cation channel subfamily M member 2, transcript variant X11
transient receptor potential cation channel subfamily M member 2, transcript variant X12
transient receptor potential cation channel subfamily M member 2 isoform X6
transient receptor potential cation channel subfamily M member 2 isoform X2
transient receptor potential cation channel subfamily M member 2 isoform X1
transient receptor potential cation channel subfamily M member 2 isoform X3
transient receptor potential cation channel subfamily M member 2 isoform X4
transient receptor potential cation channel subfamily M member 2 isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00285
cilia and flagella associated protein 410, transcript variant X1
cilia and flagella associated protein 410, transcript variant X2
cilia- and flagella-associated protein 410 isoform X1
cilia- and flagella-associated protein 410 isoform X2
ATP-dependent 6-phosphofructokinase, liver type
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
DNA (cytosine-5)-methyltransferase 3-like
inducible T cell costimulator ligand, transcript variant X1
inducible T cell costimulator ligand, transcript variant X2
inducible T cell costimulator ligand, transcript variant X3
inducible T cell costimulator ligand, transcript variant X4
glutamine amidotransferase class 1 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial isoform X3
uncharacterized LOC106824444, transcript variant X2
uncharacterized LOC106824444, transcript variant X1
uncharacterized LOC106824444, transcript variant X3
glutamine amidotransferase class 1 domain containing 3, transcript variant X1
glutamine amidotransferase class 1 domain containing 3, transcript variant X4
glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial isoform X1
glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial isoform X4
glutamine amidotransferase class 1 domain containing 3, transcript variant X2
glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial isoform X2
trafficking protein particle complex subunit 10, transcript variant X1
trafficking protein particle complex subunit 10, transcript variant X4
trafficking protein particle complex subunit 10, transcript variant X2
trafficking protein particle complex subunit 10 isoform X1
trafficking protein particle complex subunit 10 isoform X2
trafficking protein particle complex subunit 10 isoform X3
trafficking protein particle complex subunit 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
1-acylglycerol-3-phosphate O-acyltransferase 3, transcript variant X1
1-acylglycerol-3-phosphate O-acyltransferase 3, transcript variant X6
1-acylglycerol-3-phosphate O-acyltransferase 3, transcript variant X4
1-acylglycerol-3-phosphate O-acyltransferase 3, transcript variant X5
1-acylglycerol-3-phosphate O-acyltransferase 3, transcript variant X3
1-acylglycerol-3-phosphate O-acyltransferase 3, transcript variant X2
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments
ribosomal RNA processing 1, transcript variant X1
ribosomal RNA processing protein 1 homolog A isoform X1
ribosomal RNA processing 1, transcript variant X2
ribosomal RNA processing 1, transcript variant X3
ribosomal RNA processing protein 1 homolog A isoform X3
ribosomal RNA processing protein 1 homolog A isoform X2
LOW QUALITY PROTEIN: ribosomal RNA processing protein 1 homolog B
heat shock transcription factor 2 binding protein, transcript variant X2
heat shock transcription factor 2 binding protein, transcript variant X1
heat shock transcription factor 2 binding protein, transcript variant X4
heat shock transcription factor 2 binding protein, transcript variant X5
heat shock factor 2-binding protein isoform X2
heat shock factor 2-binding protein isoform X1
heat shock factor 2-binding protein isoform X4
heat shock transcription factor 2 binding protein, transcript variant X3
heat shock factor 2-binding protein isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 29 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cystathionine beta-synthase-like protein
LOW QUALITY PROTEIN: cystathionine beta-synthase-like protein
U2 small nuclear RNA auxiliary factor 1, transcript variant X1
U2 small nuclear RNA auxiliary factor 1, transcript variant X2
U2 small nuclear RNA auxiliary factor 1, transcript variant X3
splicing factor U2AF 35 kDa subunit isoform X1
splicing factor U2AF 35 kDa subunit isoform X2
splicing factor U2AF 35 kDa subunit isoform X3
PBX/knotted 1 homeobox 1, transcript variant X4
PBX/knotted 1 homeobox 1, transcript variant X3
PBX/knotted 1 homeobox 1, transcript variant X1
PBX/knotted 1 homeobox 1, transcript variant X2
NADH:ubiquinone oxidoreductase subunit V3, transcript variant X1
NADH:ubiquinone oxidoreductase subunit V3, transcript variant X4
NADH:ubiquinone oxidoreductase subunit V3, transcript variant X3
NADH:ubiquinone oxidoreductase subunit V3, transcript variant X2
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X4
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X1
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X2
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X3
NADH:ubiquinone oxidoreductase subunit V3, transcript variant X5
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X5
WD repeat domain 4, transcript variant X1
WD repeat domain 4, transcript variant X2
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 isoform X1
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 isoform X2
WD repeat domain 4, transcript variant X5
WD repeat domain 4, transcript variant X3
WD repeat domain 4, transcript variant X4
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 isoform X3
uncharacterized LOC123278357, transcript variant X2
uncharacterized LOC123278357, transcript variant X1
phosphodiesterase 9A, transcript variant X1
phosphodiesterase 9A, transcript variant X2
phosphodiesterase 9A, transcript variant X3
phosphodiesterase 9A, transcript variant X4
high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform X3
high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform X2
high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform X1
high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform X4
solute carrier family 37 member 1, transcript variant X4
solute carrier family 37 member 1, transcript variant X3
solute carrier family 37 member 1, transcript variant X6
solute carrier family 37 member 1, transcript variant X7
solute carrier family 37 member 1, transcript variant X2
solute carrier family 37 member 1, transcript variant X1
solute carrier family 37 member 1, transcript variant X5
glucose-6-phosphate exchanger SLC37A1 isoform X2
glucose-6-phosphate exchanger SLC37A1 isoform X1
glucose-6-phosphate exchanger SLC37A1 isoform X3
radial spoke head component 1, transcript variant X1
radial spoke head component 1, transcript variant X2
ubiquitin associated and SH3 domain containing A
LOW QUALITY PROTEIN: ubiquitin-associated and SH3 domain-containing protein A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily G member 1, transcript variant X1
ATP binding cassette subfamily G member 1, transcript variant X3
ATP-binding cassette sub-family G member 1 isoform X3
ATP-binding cassette sub-family G member 1 isoform X1
ATP binding cassette subfamily G member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ATP-binding cassette sub-family G member 1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123278339, transcript variant X1
uncharacterized LOC123278339, transcript variant X2
zinc finger and BTB domain containing 21, transcript variant X1
zinc finger and BTB domain containing 21, transcript variant X6
zinc finger and BTB domain containing 21, transcript variant X5
zinc finger and BTB domain containing 21, transcript variant X4
zinc finger and BTB domain containing 21, transcript variant X2
zinc finger and BTB domain containing 21, transcript variant X3
zinc finger and BTB domain-containing protein 21 isoform X1
zinc finger and BTB domain-containing protein 21 isoform X2
C2 calcium dependent domain containing 2, transcript variant X1
C2 domain-containing protein 2 isoform X1
C2 calcium dependent domain containing 2, transcript variant X3
C2 domain-containing protein 2 isoform X3
C2 calcium dependent domain containing 2, transcript variant X2
C2 domain-containing protein 2 isoform X2
PR domain zinc finger protein 15 isoform X1
PR domain zinc finger protein 15 isoform X2
receptor interacting serine/threonine kinase 4, transcript variant X2
receptor-interacting serine/threonine-protein kinase 4 isoform X2
receptor interacting serine/threonine kinase 4, transcript variant X1
receptor-interacting serine/threonine-protein kinase 4 isoform X1
uncharacterized LOC123278299, transcript variant X2
uncharacterized LOC123278299, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106829942, transcript variant X2
uncharacterized LOC106829942, transcript variant X1
LOW QUALITY PROTEIN: transmembrane protease serine 2
MX dynamin like GTPase 1, transcript variant X1
MX dynamin like GTPase 1, transcript variant X2
interferon-induced GTP-binding protein Mx1
MX dynamin like GTPase 2, transcript variant X1
MX dynamin like GTPase 2, transcript variant X3
MX dynamin like GTPase 2, transcript variant X2
interferon-induced GTP-binding protein Mx2 isoform X1
MX dynamin like GTPase 2, transcript variant X4
interferon-induced GTP-binding protein Mx2 isoform X2
FAM3 metabolism regulating signaling molecule B, transcript variant X2
FAM3 metabolism regulating signaling molecule B, transcript variant X1
uncharacterized LOC106829960, transcript variant X3
uncharacterized LOC106829960, transcript variant X2
uncharacterized LOC106829960, transcript variant X1
uncharacterized LOC123278303, transcript variant X2
uncharacterized LOC123278303, transcript variant X1
immunoglobulin superfamily member 5, transcript variant X2
immunoglobulin superfamily member 5, transcript variant X1
immunoglobulin superfamily member 5, transcript variant X4
immunoglobulin superfamily member 5, transcript variant X3
immunoglobulin superfamily member 5 isoform X3
immunoglobulin superfamily member 5 isoform X2
immunoglobulin superfamily member 5 isoform X1
uncharacterized LOC123278279, transcript variant X2
uncharacterized LOC123278279, transcript variant X1
uncharacterized LOC123278343, transcript variant X3
uncharacterized LOC123278343, transcript variant X2
uncharacterized LOC123278343, transcript variant X1
beta-1,3-galactosyltransferase 5, transcript variant X1
beta-1,3-galactosyltransferase 5, transcript variant X2
beta-1,3-galactosyltransferase 5, transcript variant X3
SH3 domain-binding glutamic acid-rich protein, transcript variant X3
SH3 domain-binding glutamic acid-rich protein, transcript variant X5
SH3 domain-binding glutamic acid-rich protein, transcript variant X4
SH3 domain-binding glutamic acid-rich protein, transcript variant X7
SH3 domain-binding glutamic acid-rich protein, transcript variant X2
SH3 domain-binding glutamic acid-rich protein, transcript variant X1
SH3 domain-binding glutamic acid-rich protein isoform X2
SH3 domain-binding glutamic acid-rich protein isoform X1
SH3 domain-binding glutamic acid-rich protein isoform X5
SH3 domain-binding glutamic acid-rich protein isoform X3
SH3 domain-binding glutamic acid-rich protein, transcript variant X6
SH3 domain-binding glutamic acid-rich protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: lebercilin-like protein
guided entry of tail-anchored proteins factor 1
high mobility group nucleosome binding domain 1
uncharacterized LOC123278349, transcript variant X1
uncharacterized LOC123278349, transcript variant X2
uncharacterized protein LOC123278349 isoform X1
uncharacterized protein LOC123278349 isoform X2
bromodomain and WD repeat domain containing 1, transcript variant X3
bromodomain and WD repeat domain containing 1, transcript variant X1
bromodomain and WD repeat domain containing 1, transcript variant X2
bromodomain and WD repeat-containing protein 1 isoform X3
bromodomain and WD repeat-containing protein 1 isoform X1
bromodomain and WD repeat-containing protein 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
proteasome assembly chaperone 1, transcript variant X1
proteasome assembly chaperone 1, transcript variant X3
proteasome assembly chaperone 1, transcript variant X2
proteasome assembly chaperone 1 isoform X1
proteasome assembly chaperone 1 isoform X2
proteasome assembly chaperone 1 isoform X3
uncharacterized LOC123278323, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123278323, transcript variant X3
uncharacterized LOC123278323, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
ETS proto-oncogene 2, transcription factor
uncharacterized LOC123278324, transcript variant X1
uncharacterized LOC123278324, transcript variant X2
ETS transcription factor ERG, transcript variant X2
ETS transcription factor ERG, transcript variant X6
ETS transcription factor ERG, transcript variant X5
ETS transcription factor ERG, transcript variant X1
ETS transcription factor ERG, transcript variant X8
ETS transcription factor ERG, transcript variant X3
uncharacterized LOC123278246, transcript variant X2
uncharacterized LOC123278246, transcript variant X1
ETS transcription factor ERG, transcript variant X4
transcriptional regulator ERG isoform X1
transcriptional regulator ERG isoform X2
transcriptional regulator ERG isoform X3
ETS transcription factor ERG, transcript variant X7
transcriptional regulator ERG isoform X4
transcriptional regulator ERG isoform X5
ETS transcription factor ERG, transcript variant X9
transcriptional regulator ERG isoform X6
uncharacterized LOC123278266, transcript variant X2
uncharacterized LOC123278266, transcript variant X3
uncharacterized LOC123278266, transcript variant X1
potassium inwardly rectifying channel subfamily J member 15, transcript variant X1
potassium inwardly rectifying channel subfamily J member 15, transcript variant X7
potassium inwardly rectifying channel subfamily J member 15, transcript variant X5
potassium inwardly rectifying channel subfamily J member 15, transcript variant X6
potassium inwardly rectifying channel subfamily J member 15, transcript variant X4
potassium inwardly rectifying channel subfamily J member 15, transcript variant X3
potassium inwardly rectifying channel subfamily J member 15, transcript variant X2
ATP-sensitive inward rectifier potassium channel 15
uncharacterized LOC123278370, transcript variant X1
uncharacterized LOC123278370, transcript variant X2
potassium inwardly rectifying channel subfamily J member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 2
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X2
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X7
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X4
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X3
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X8
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X6
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X1
dual specificity tyrosine phosphorylation regulated kinase 1A, transcript variant X5
dual specificity tyrosine-phosphorylation-regulated kinase 1A isoform X2
dual specificity tyrosine-phosphorylation-regulated kinase 1A isoform X1
dual specificity tyrosine-phosphorylation-regulated kinase 1A isoform X3
uncharacterized LOC123278283, transcript variant X1
uncharacterized LOC123278283, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
VPS26 endosomal protein sorting factor C, transcript variant X3
VPS26 endosomal protein sorting factor C, transcript variant X1
VPS26 endosomal protein sorting factor C, transcript variant X2
vacuolar protein sorting-associated protein 26C isoform X2
vacuolar protein sorting-associated protein 26C isoform X1
vacuolar protein sorting-associated protein 26C isoform X3
tetratricopeptide repeat domain 3, transcript variant X5
tetratricopeptide repeat domain 3, transcript variant X3
tetratricopeptide repeat domain 3, transcript variant X2
tetratricopeptide repeat domain 3, transcript variant X9
tetratricopeptide repeat domain 3, transcript variant X8
tetratricopeptide repeat domain 3, transcript variant X4
tetratricopeptide repeat domain 3, transcript variant X1
tetratricopeptide repeat domain 3, transcript variant X7
E3 ubiquitin-protein ligase TTC3 isoform X3
E3 ubiquitin-protein ligase TTC3 isoform X2
E3 ubiquitin-protein ligase TTC3 isoform X1
E3 ubiquitin-protein ligase TTC3 isoform X5
tetratricopeptide repeat domain 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
E3 ubiquitin-protein ligase TTC3 isoform X4
phosphatidylinositol glycan anchor biosynthesis class P, transcript variant X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit P isoform X1
phosphatidylinositol glycan anchor biosynthesis class P, transcript variant X4
phosphatidylinositol glycan anchor biosynthesis class P, transcript variant X5
phosphatidylinositol glycan anchor biosynthesis class P, transcript variant X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit P isoform X2
phosphatidylinositol glycan anchor biosynthesis class P, transcript variant X3
phosphatidylinositol N-acetylglucosaminyltransferase subunit P isoform X3
ripply transcriptional repressor 3, transcript variant X1
ripply transcriptional repressor 3, transcript variant X2
holocarboxylase synthetase, transcript variant X1
holocarboxylase synthetase, transcript variant X2
holocarboxylase synthetase, transcript variant X3
holocarboxylase synthetase, transcript variant X5
holocarboxylase synthetase, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: single-minded homolog 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromatin assembly factor 1 subunit B, transcript variant X2
chromatin assembly factor 1 subunit B, transcript variant X3
chromatin assembly factor 1 subunit B, transcript variant X1
MORC family CW-type zinc finger 3, transcript variant X1
MORC family CW-type zinc finger 3, transcript variant X2
MORC family CW-type zinc finger protein 3 isoform X1
MORC family CW-type zinc finger protein 3 isoform X2
DOP1 leucine zipper like protein B, transcript variant X2
DOP1 leucine zipper like protein B, transcript variant X1
DOP1 leucine zipper like protein B, transcript variant X5
DOP1 leucine zipper like protein B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
DOP1 leucine zipper like protein B, transcript variant X4
SET domain containing 4, transcript variant X8
SET domain containing 4, transcript variant X4
SET domain containing 4, transcript variant X7
carbonyl reductase 3, transcript variant X2
carbonyl reductase 3, transcript variant X1
SET domain-containing protein 4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
SET domain containing 4, transcript variant X3
SET domain containing 4, transcript variant X2
SET domain containing 4, transcript variant X1
SET domain containing 4, transcript variant X10
SET domain-containing protein 4 isoform X1
SET domain-containing protein 4 isoform X3
SET domain-containing protein 4 isoform X2
SET domain containing 4, transcript variant X5
SET domain containing 4, transcript variant X6
SET domain containing 4, transcript variant X9
SET domain-containing protein 4 isoform X5
uncharacterized LOC123278353, transcript variant X2
uncharacterized LOC123278353, transcript variant X1
uncharacterized LOC123278353, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RUNX family transcription factor 1, transcript variant X11
RUNX family transcription factor 1, transcript variant X4
RUNX family transcription factor 1, transcript variant X5
runt-related transcription factor 1 isoform X4
runt-related transcription factor 1 isoform X10
RUNX family transcription factor 1, transcript variant X8
RUNX family transcription factor 1, transcript variant X7
RUNX family transcription factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RUNX family transcription factor 1, transcript variant X1
RUNX family transcription factor 1, transcript variant X2
runt-related transcription factor 1 isoform X6
runt-related transcription factor 1 isoform X2
runt-related transcription factor 1 isoform X1
runt-related transcription factor 1 isoform X5
runt-related transcription factor 1 isoform X7
RUNX family transcription factor 1, transcript variant X3
runt-related transcription factor 1 isoform X3
RUNX family transcription factor 1, transcript variant X9
RUNX family transcription factor 1, transcript variant X10
runt-related transcription factor 1 isoform X8
runt-related transcription factor 1 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: chloride intracellular channel protein 6
uncharacterized LOC123278248, transcript variant X2
uncharacterized LOC123278248, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
potassium voltage-gated channel subfamily E regulatory subunit 1
LOW QUALITY PROTEIN: potassium voltage-gated channel subfamily E member 1
LOW QUALITY PROTEIN: small integral membrane protein 34A
small integral membrane protein 11, transcript variant X3
small integral membrane protein 11, transcript variant X1
small integral membrane protein 11, transcript variant X4
small integral membrane protein 11, transcript variant X2
potassium voltage-gated channel subfamily E regulatory subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily E member 2
uncharacterized LOC106832815, transcript variant X5
uncharacterized LOC106832815, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC106832815, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC106832815, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC106832815, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC106832815, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC106832815, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC106832815, transcript variant X9
uncharacterized LOC106832815, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mitochondrial ribosomal protein S6, transcript variant X2
mitochondrial ribosomal protein S6, transcript variant X1
28S ribosomal protein S6, mitochondrial isoform X2
28S ribosomal protein S6, mitochondrial isoform X1
solute carrier family 5 member 3, transcript variant X4
solute carrier family 5 member 3, transcript variant X1
solute carrier family 5 member 3, transcript variant X2
solute carrier family 5 member 3, transcript variant X3
ATP synthase peripheral stalk subunit OSCP
uncharacterized LOC123278270, transcript variant X3
uncharacterized LOC123278270, transcript variant X1
uncharacterized LOC123278270, transcript variant X2
uncharacterized LOC123278270, transcript variant X4
basic salivary proline-rich protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
crystallin zeta like 1, transcript variant X3
crystallin zeta like 1, transcript variant X1
crystallin zeta like 1, transcript variant X2
crystallin zeta like 1, transcript variant X9
crystallin zeta like 1, transcript variant X5
crystallin zeta like 1, transcript variant X6
crystallin zeta like 1, transcript variant X10
crystallin zeta like 1, transcript variant X8
crystallin zeta like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
crystallin zeta like 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
quinone oxidoreductase-like protein 1 isoform X1
quinone oxidoreductase-like protein 1 isoform X2
quinone oxidoreductase-like protein 1 isoform X9
quinone oxidoreductase-like protein 1 isoform X3
quinone oxidoreductase-like protein 1 isoform X8
quinone oxidoreductase-like protein 1 isoform X5
quinone oxidoreductase-like protein 1 isoform X6
quinone oxidoreductase-like protein 1 isoform X7
quinone oxidoreductase-like protein 1 isoform X4
DNA replication fork stabilization factor DONSON, transcript variant X1
DNA replication fork stabilization factor DONSON, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
SON DNA and RNA binding protein, transcript variant X1
SON DNA and RNA binding protein, transcript variant X2
SON DNA and RNA binding protein, transcript variant X3
SON DNA and RNA binding protein, transcript variant X4
SON DNA and RNA binding protein, transcript variant X5
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
trifunctional purine biosynthetic protein adenosine-3
uncharacterized LOC123278269, transcript variant X2
uncharacterized LOC123278269, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C28
LOW QUALITY PROTEIN: dnaJ homolog subfamily C member 28
transmembrane protein 50B, transcript variant X1
transmembrane protein 50B, transcript variant X2
transmembrane protein 50B, transcript variant X3
transmembrane protein 50B, transcript variant X4
interferon alpha and beta receptor subunit 1
uncharacterized LOC106832841, transcript variant X2
uncharacterized LOC106832841, transcript variant X5
uncharacterized LOC106832841, transcript variant X4
uncharacterized LOC106832841, transcript variant X6
uncharacterized LOC106832841, transcript variant X3
uncharacterized LOC106832841, transcript variant X1
interferon alpha and beta receptor subunit 2, transcript variant X6
interferon alpha and beta receptor subunit 2, transcript variant X5
interferon alpha and beta receptor subunit 2, transcript variant X4
interferon alpha and beta receptor subunit 2, transcript variant X2
interferon alpha and beta receptor subunit 2, transcript variant X8
interferon alpha and beta receptor subunit 2, transcript variant X7
interferon alpha and beta receptor subunit 2, transcript variant X3
interferon alpha and beta receptor subunit 2, transcript variant X1
interferon alpha/beta receptor 2 isoform X2
interferon alpha/beta receptor 2 isoform X1
interferon alpha/beta receptor 2 isoform X3
interferon alpha/beta receptor 2 isoform X4
interferon alpha and beta receptor subunit 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
interferon alpha/beta receptor 2 isoform X5
uncharacterized LOC123278351, transcript variant X3
uncharacterized LOC123278351, transcript variant X1
uncharacterized LOC123278351, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein C21orf62 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cilia and flagella associated protein 298, transcript variant X1
cilia- and flagella-associated protein 298 isoform X1
cilia and flagella associated protein 298, transcript variant X2
cilia- and flagella-associated protein 298 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 192 Proteins
URB1 ribosome biogenesis homolog, transcript variant X1
URB1 ribosome biogenesis homolog, transcript variant X2
URB1 ribosome biogenesis homolog, transcript variant X3
URB1 ribosome biogenesis homolog, transcript variant X4
nucleolar pre-ribosomal-associated protein 1 isoform X1
nucleolar pre-ribosomal-associated protein 1 isoform X2
nucleolar pre-ribosomal-associated protein 1 isoform X3
nucleolar pre-ribosomal-associated protein 1 isoform X4
melanocortin 2 receptor accessory protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
melanocortin 2 receptor accessory protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
melanocortin-2 receptor accessory protein isoform X2
melanocortin-2 receptor accessory protein isoform X1
MIS18 kinetochore protein A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MIS18 kinetochore protein A, transcript variant X1
hormonally up-regulated Neu-associated kinase
hormonally up-regulated neu tumor-associated kinase
melanoma inhibitory activity protein 2-like
SR-related CTD associated factor 4, transcript variant X1
SR-related CTD associated factor 4, transcript variant X4
SR-related CTD associated factor 4, transcript variant X2
SR-related CTD associated factor 4, transcript variant X3
SR-related and CTD-associated factor 4 isoform X1
SR-related and CTD-associated factor 4 isoform X4
SR-related and CTD-associated factor 4 isoform X2
SR-related and CTD-associated factor 4 isoform X3
TIAM Rac1 associated GEF 1, transcript variant X1
TIAM Rac1 associated GEF 1, transcript variant X3
TIAM Rac1 associated GEF 1, transcript variant X2
TIAM Rac1 associated GEF 1, transcript variant X4
rho guanine nucleotide exchange factor TIAM1 isoform X1
rho guanine nucleotide exchange factor TIAM1 isoform X2
TIAM Rac1 associated GEF 1, transcript variant X5
TIAM Rac1 associated GEF 1, transcript variant X6
rho guanine nucleotide exchange factor TIAM1 isoform X3
rho guanine nucleotide exchange factor TIAM1 isoform X4
uncharacterized LOC123278286, transcript variant X2
uncharacterized LOC123278286, transcript variant X1
uncharacterized LOC123278286, transcript variant X3
uncharacterized LOC123278287, transcript variant X2
uncharacterized LOC123278287, transcript variant X1
uncharacterized LOC123278285, transcript variant X3
uncharacterized LOC123278285, transcript variant X1
uncharacterized LOC123278285, transcript variant X2
uncharacterized LOC123278285, transcript variant X6
uncharacterized LOC123278285, transcript variant X5
uncharacterized LOC123278285, transcript variant X4
uncharacterized LOC123278332, transcript variant X2
uncharacterized LOC123278332, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: keratin-associated protein 23-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 23 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
LOW QUALITY PROTEIN: keratin-associated protein 23-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
glutamate ionotropic receptor kainate type subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
glutamate ionotropic receptor kainate type subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
glutamate ionotropic receptor kainate type subunit 1, transcript variant X2
glutamate receptor ionotropic, kainate 1 isoform X1
glutamate receptor ionotropic, kainate 1 isoform X3
glutamate receptor ionotropic, kainate 1 isoform X2
BTB domain and CNC homolog 1, transcript variant X2
BTB domain and CNC homolog 1, transcript variant X1
BTB domain and CNC homolog 1, transcript variant X4
BTB domain and CNC homolog 1, transcript variant X3
transcription regulator protein BACH1 isoform X1
BTB domain and CNC homolog 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transcription regulator protein BACH1 isoform X2
MAP3K7 C-terminal like, transcript variant X2
MAP3K7 C-terminal like, transcript variant X1
MAP3K7 C-terminal like, transcript variant X3
MAP3K7 C-terminal like, transcript variant X4
MAP3K7 C-terminal like, transcript variant X7
MAP3K7 C-terminal like, transcript variant X6
MAP3K7 C-terminal like, transcript variant X5
MAP3K7 C-terminal-like protein isoform X1
MAP3K7 C-terminal-like protein isoform X2
ubiquitin specific peptidase 16, transcript variant X4
ubiquitin specific peptidase 16, transcript variant X2
ubiquitin specific peptidase 16, transcript variant X1
ubiquitin specific peptidase 16, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 16
RWD domain containing 2B, transcript variant X4
RWD domain containing 2B, transcript variant X2
RWD domain containing 2B, transcript variant X1
RWD domain containing 2B, transcript variant X5
RWD domain containing 2B, transcript variant X3
listerin E3 ubiquitin protein ligase 1, transcript variant X1
listerin E3 ubiquitin protein ligase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
E3 ubiquitin-protein ligase listerin isoform X1
E3 ubiquitin-protein ligase listerin isoform X2
N-6 adenine-specific DNA methyltransferase 1, transcript variant X3
N-6 adenine-specific DNA methyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
N-6 adenine-specific DNA methyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-6 adenine-specific DNA methyltransferase 1, transcript variant X5
N-6 adenine-specific DNA methyltransferase 1, transcript variant X4
uncharacterized LOC123278278, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123278278, transcript variant X2
uncharacterized LOC123278335, transcript variant X2
uncharacterized LOC123278335, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 5
A disintegrin and metalloproteinase with thrombospondin motifs 5
ADAM metallopeptidase with thrombospondin type 1 motif 1
A disintegrin and metalloproteinase with thrombospondin motifs 1
amyloid beta precursor protein, transcript variant X1
amyloid beta precursor protein, transcript variant X2
amyloid beta precursor protein, transcript variant X3
amyloid beta precursor protein, transcript variant X4
amyloid beta precursor protein, transcript variant X5
amyloid beta precursor protein, transcript variant X6
amyloid-beta precursor protein isoform X1
amyloid-beta precursor protein isoform X2
amyloid-beta precursor protein isoform X3
amyloid-beta precursor protein isoform X4
amyloid-beta precursor protein isoform X5
amyloid-beta precursor protein isoform X6
GA binding protein transcription factor subunit alpha, transcript variant X2
GA binding protein transcription factor subunit alpha, transcript variant X4
GA binding protein transcription factor subunit alpha, transcript variant X3
GA binding protein transcription factor subunit alpha, transcript variant X1
uncharacterized LOC123278222, transcript variant X3
uncharacterized LOC123278222, transcript variant X2
uncharacterized LOC123278222, transcript variant X1
ATP synthase peripheral stalk subunit F6, transcript variant X2
ATP synthase peripheral stalk subunit F6, transcript variant X3
ATP synthase peripheral stalk subunit F6, transcript variant X1
ATP synthase-coupling factor 6, mitochondrial
junctional adhesion molecule 2, transcript variant X5
junctional adhesion molecule 2, transcript variant X1
junctional adhesion molecule B isoform X1
junctional adhesion molecule 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
junctional adhesion molecule B isoform X3
junctional adhesion molecule 2, transcript variant X2
junctional adhesion molecule B isoform X2
junctional adhesion molecule 2, transcript variant X4
junctional adhesion molecule B isoform X4
39S ribosomal protein L39, mitochondrial
uncharacterized LOC106843188, transcript variant X2
uncharacterized LOC106843188, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA
uncharacterized LOC123278368, transcript variant X2
uncharacterized LOC123278368, transcript variant X1
uncharacterized LOC123278368, transcript variant X3
uncharacterized LOC123278368, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 135 Proteins
uncharacterized LOC123278309, transcript variant X2
uncharacterized LOC123278309, transcript variant X1
neural cell adhesion molecule 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neural cell adhesion molecule 2 isoform X1
neural cell adhesion molecule 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neural cell adhesion molecule 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
chromosome 18 C21orf91 homolog, transcript variant X1
chromosome 18 C21orf91 homolog, transcript variant X2
chromosome 18 C21orf91 homolog, transcript variant X3
BTG anti-proliferation factor 3, transcript variant X1
BTG anti-proliferation factor 3, transcript variant X2
BTG anti-proliferation factor 3, transcript variant X3
CXADR Ig-like cell adhesion molecule, transcript variant X1
CXADR Ig-like cell adhesion molecule, transcript variant X2
coxsackievirus and adenovirus receptor isoform X1
coxsackievirus and adenovirus receptor isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123278369, transcript variant X1
uncharacterized LOC123278369, transcript variant X2
uncharacterized LOC106848302, transcript variant X4
uncharacterized LOC106848302, transcript variant X5
uncharacterized LOC106848302, transcript variant X3
uncharacterized LOC106848302, transcript variant X10
uncharacterized LOC106848302, transcript variant X2
uncharacterized LOC106848302, transcript variant X1
uncharacterized LOC106848302, transcript variant X6
uncharacterized LOC106848302, transcript variant X7
uncharacterized LOC106848302, transcript variant X15
uncharacterized LOC106848302, transcript variant X9
uncharacterized LOC106848302, transcript variant X12
uncharacterized LOC106848302, transcript variant X11
uncharacterized LOC106848302, transcript variant X13
uncharacterized LOC106848302, transcript variant X14
uncharacterized LOC106848302, transcript variant X8
uncharacterized LOC106848301, transcript variant X2
uncharacterized LOC106848301, transcript variant X3
uncharacterized LOC106848301, transcript variant X1
uncharacterized LOC106848301, transcript variant X4
uncharacterized protein LOC106848301 isoform X2
uncharacterized protein LOC106848301 isoform X3
uncharacterized protein LOC106848301 isoform X1
uncharacterized protein LOC106848301 isoform X4
uncharacterized LOC106848297, transcript variant X2
uncharacterized LOC106848297, transcript variant X1
ubiquitin specific peptidase 25, transcript variant X2
ubiquitin specific peptidase 25, transcript variant X4
ubiquitin specific peptidase 25, transcript variant X1
ubiquitin specific peptidase 25, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 25 isoform X4
ubiquitin carboxyl-terminal hydrolase 25 isoform X2
ubiquitin carboxyl-terminal hydrolase 25 isoform X1
ubiquitin carboxyl-terminal hydrolase 25 isoform X3